Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alcon, Inc.,
New cataract removal system debuted; conjunctivitis drug approved
May 14th, 2003
The newest technology in cataract removal devices debuted at the Alcon, Inc., (ACL) exhibit during the American Society of Cataract and Refractive Surgery (ASCRS) Symposium in San Francisco and the company announced that the U.S. Food and Drug Administration (FDA) has approved its conjunctivitis drug. Alcon's new Infiniti Vision System is the world's first trimodal cataract removal surgical instrument. With this single instrument, surgeons now have a choice of three different methods to remove a cataract: Advanced ultrasound phacoemulsification alone, The combination of ultrasound and oscillation provided by the NeoSoniX handpiece, or ...
Source: Biotech Week (2003-05-14)
|
